Cytovene - 0004-6940-03 - (ganciclovir sodium)

Alphabetical Index


Drug Information of Cytovene

Product NDC: 0004-6940
Proprietary Name: Cytovene
Non Proprietary Name: ganciclovir sodium
Active Ingredient(s): 500    mg/10mL & nbsp;   ganciclovir sodium
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Cytovene

Product NDC: 0004-6940
Labeler Name: Genentech, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019661
Marketing Category: NDA
Start Marketing Date: 19890623

Package Information of Cytovene

Package NDC: 0004-6940-03
Package Description: 25 VIAL in 1 CARTON (0004-6940-03) > 10 mL in 1 VIAL

NDC Information of Cytovene

NDC Code 0004-6940-03
Proprietary Name Cytovene
Package Description 25 VIAL in 1 CARTON (0004-6940-03) > 10 mL in 1 VIAL
Product NDC 0004-6940
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ganciclovir sodium
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19890623
Marketing Category Name NDA
Labeler Name Genentech, Inc.
Substance Name GANCICLOVIR SODIUM
Strength Number 500
Strength Unit mg/10mL
Pharmaceutical Classes Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC]

Complete Information of Cytovene


General Information